[Maternal and foetal prognostic during severe toxemia]

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Perinatology

Context:

• Severe gravidic toxemia (preeclampsia/eclampsia) presents a significant global health challenge, contributing to substantial maternal and fetal morbidity and mortality.
• Understanding the specific risk factors and prognostic indicators is crucial for improving clinical management and patient outcomes in high-risk pregnancies.

Purpose:

• To identify and analyze factors associated with adverse maternal and fetal prognostic outcomes in cases of severe and complicated gravidic toxemia.
• To evaluate the incidence of specific severe maternal complications and perinatal issues in a cohort of patients with severe toxemia.

Summary:

• A retrospective analysis of 100 severe toxemia cases at the Military Hospital of Tunis revealed that maternal morbidity was primarily linked to hypertensive complications and blood disorders.
• Key findings included eclampsia (4 cases), retroplacental hematoma (9 cases), and HELLP syndrome (5 cases). While no maternal deaths occurred, perinatal mortality was 28.8%, with high rates of intrauterine growth restriction (43.8%) and prematurity (65.9%).
• The study emphasized that earlier onset of toxemia during pregnancy correlates with poorer maternal and fetal prognoses.

Impact:

• Highlights the critical need for early detection and timely intervention in pregnancies complicated by severe toxemia to mitigate severe maternal and fetal complications.
• Provides valuable data for refining clinical guidelines and improving management strategies for severe toxemia, particularly in resource-limited settings.
• Informs public health initiatives aimed at reducing the burden of hypertensive disorders of pregnancy and improving perinatal outcomes.